Skip to main content
. 2021 Jan 29;18(6):1456–1464. doi: 10.7150/ijms.51256

Figure 3.

Figure 3

LY3214996 increased sorafenib inhibition of Huh7R cell migration. (A and B) Wound healing assays were carried out to assess cell migration of Huh7R cells treated with sorafenib, LY3214996, or the combination of the two for 12 h and 24 h. (C and D) Related proteins of tumor-cell migration (MMP-2 and MMP-9) were detected by western blot. (E) A proposed working model of how LY3214996 acts on the Ras/Raf/MAPK pathway to affect migration of Huh7R cells. Data are expressed as mean ± SD of three independent experiments (* p < 0.05; **p < 0.01; ***p < 0.001).